Status:
COMPLETED
Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean Sections
Lead Sponsor:
Ain Shams University
Conditions:
Anesthesia; Adverse Effect, Spinal and Epidural
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean Sections
Detailed Description
Shivering is known to be a frequent complication, reported in 40 to 70% of patients undergoing surgery under regional anaesthesia. Shivering is a potentially serious complication, resulting in increas...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- elective for caesarian section presence of post-spinal shivering, defined as involuntary muscle contractions occurring within operative and early recovery period after cesarean delivery.
- Age 18 - 45
- Exclusion Criteria
- Inability to provide informed consent.
- Previous allergies or sensitivities to granisetron or pethidine.
- Current use of medications that may interact with granisetron or pethidine.
- Presence of other conditions that may contraindicate the use of granisetron or pethidine, such as known liver or kidney disease.
- Patients who are too short (\<140 cm) or too tall (\>190 cm)
Exclusion
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 28 2024
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT06513806
Start Date
August 1 2024
End Date
September 28 2024
Last Update
October 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt